3 Mar 2021 07:00
RNS Number : 9323Q
FastForward Innovations Limited
03 March 2021
FastForward Innovations Ltd / AIM: FFWD / Sector: Closed End Investments
3 March 2021
FastForward Innovations Ltd ("FastForward" or, "FFWD")
New Corporate Presentation
FastForward Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses, is pleased to announce that its new corporate presentation will be available on its website today at www.fstfwd.co.
ENDS
For further information on the Company please visit www.fstfwd.co or contact:
Ed McDermott Lance de Jersey | FastForward Innovations Ltd | E: info@fstfwd.co |
James Biddle Roland Cornish | Beaumont Cornish Limited, Nomad | T: (0)20 7628 3396 |
Isabella Pierre Damon Heath | Shard Capital Partners LLP Broker | T: (0)20 7186 9927 |
Catherine Leftley Beth Melluish | St Brides Partners Ltd, Financial PR | E: info@stbridespartners.co.uk |
Notes
FastForward Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NRAKLLFBFXLBBBE
